How does probenecid change tigecycline's antibacterial mechanism?

Short answer: Probenecid does not change tigecycline’s antibacterial mechanism. Tigecycline’s action on the bacterial ribosome remains the same; probenecid just isn’t known to alter that target.

Details you might find helpful:
- Tigecycline MOA: It binds to the 30S ribosomal subunit, inhibits binding of aminoacyl-tRNA, and thereby blocks protein synthesis (bacteriostatic).
- Probenecid MOA: It inhibits renal organic anion transporters (OATs), reducing renal excretion of some drugs and prolonging their plasma levels. It mainly affects drugs that are cleared renally via secretion.
- PK interaction with tigecycline: Tigecycline is eliminated mainly by biliary/fecal routes (>80%), with only a small fraction excreted unchanged in urine. Because renal clearance is not the main elimination pathway, the impact of probenecid on tigecycline exposure is expected to be minimal.
- Clinical significance: There is no well-established, clinically important drug interaction between probenecid and tigecycline. No dose adjustment is generally needed based on this interaction, and the antibacterial mechanism of tigecycline remains unchanged.

If you’re considering this combination for a patient, it’s still wise to consult current drug interaction resources or clinical guidelines, but the expectation is that probenecid won’t meaningfully alter tigecycline’s mechanism or effectiveness.